연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1777. Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation.
Ju HY, Kang HJ, Hong CR, Lee JW, Kim H, Park KD, Shin HY, Park JD, Choi EH, Lee HJ, Ahn HS.
Transpl Infect Dis. 2016 Jun;18(3):396-404. doi: 10.1111/tid.12539. Epub 2016 Jun 9.
Link
1776. Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers.
Kim JH, Park HE, Cho NY, Lee HS, Kang GH.
Br J Cancer. 2016 Aug 9;115(4):490-6. doi: 10.1038/bjc.2016.211. Epub 2016 Jul 12.
Link
1775. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH, Bae JM, Cho NY, Kang GH.
Oncotarget. 2016 Mar 22;7(12):14095-111. doi: 10.18632/oncotarget.7374.
Link
1774. Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma.
Kim JH, Bae JM, Song YS, Cho NY, Lee HS, Kang GH.
Oncotarget. 2016 Mar 22;7(12):13372-87. doi: 10.18632/oncotarget.5618.
Link
1773. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM1, Rhee YY2, Kim KJ3, Wen X4, Song YS5, Cho NY6, Kim JH7, Kang GH8.
Hum Pathol. 2016 Jan;47(1):85-94. doi: 10.1016/j.humpath.2015.09.008. Epub 2015 Sep 25.
Link
1772. Distribution of intestinal stem cell markers in colorectal precancerous lesions.
Jang BG, Kim HS, Kim KJ, Rhee YY, Kim WH, Kang GH.
Histopathology. 2016 Mar;68(4):567-77. doi: 10.1111/his.12787. Epub 2015 Sep 11.
Link
1771. Methylation status of long interspersed element-1 in advanced gastric cancer and its prognostic implication.
Song YS, Kim Y, Cho NY, Yang HK, Kim WH, Kang GH.
Gastric Cancer. 2016 Jan;19(1):98-106. doi: 10.1007/s10120-015-0463-6. Epub 2015 Jan 22.
Link
1770. Development of Drugs and Technology for Radiation Theragnosis
Hwan-Jeong Jeonga, Byung Chul Leeb, c, Byeong-Cheol Ahnd, Keon Wook Kange
Nuclear Engineering and Technology Volume 48, Issue 3, June 2016, Pages 597–607
1769. Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.
Kim YI, Yoon HJ, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kim EE, Moon WK, Kang KW.
Clin Nucl Med. 2016 Aug;41(8):614-20. doi: 10.1097/RLU.0000000000001274.
Link
1768. History and Organizations for Radiological Protection.
Kang KW.
J Korean Med Sci. 2016 Feb;31 Suppl 1:S4-5. doi: 10.3346/jkms.2016.31.S1.S4. Epub 2016 Jan 29.
Link